about
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
Read More
0.88
0.01
(1.15%)
54,089
XNAS Volume
XNAS 20 Jun, 2025 9:48 AM (EDT)
Board Meeting
The next board meeting for Kronos Bio Inc is on 22 Jul 2025 for the purpose of Kronos Bio Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Kronos Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..